Cardiac implantable electronic device infection awareness – A European survey amongst implanting physicians Posted on September 17th, 2024 by Betsy Stovsky Post navigation Previous: FDA approves Biotronik lead, catheter for left bundle branch area pacingNext: Feasibility, timing and outcome of leadless cardiac pacemaker implantation in patients undergoing cardiac implantable electronic device extraction.
Indications for Lead Extraction Posted on September 11th, 2024 by LEADconnection Post navigation Previous: Selection of candidates for cardiac resynchronization therapy and implantation management: an Italian survey promoted by the Italian Association of Arrhythmology and Cardiac Pacing.Next: BIOTRONIK Receives FDA Approval for LBBAP Indication on Pacing Lead and Delivery Catheter System
Selection of candidates for cardiac resynchronization therapy and implantation management: an Italian survey promoted by the Italian Association of Arrhythmology and Cardiac Pacing. Posted on August 22nd, 2024 by LEADconnection Post navigation Previous: His bundle pacing versus left bundle branch area pacing in patients undergoing atrioventricular node ablation: A prospective and comparative study.Next: Indications for Lead Extraction